Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Commentary on Hey and Kimmelman.

Literature DB >> 25649110

Commentary on Hey and Kimmelman.

J Jack Lee¹.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2015 PMID： 25649110 PMCID： PMC4492278 DOI： 10.1177/1740774514568875

Source DB: PubMed Journal: Clin Trials ISSN： 1740-7745 Impact factor: 2.486

× No keyword cloud information.

18 in total

Review 1. Adaptive randomization for clinical trials.

Authors: William F Rosenberger; Oleksandr Sverdlov; Feifang Hu
Journal: J Biopharm Stat Date: 2012 Impact factor: 1.051

2. Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spot.

Authors: Byron J Gajewski; Scott M Berry; Melanie Quintana; Mamatha Pasnoor; Mazen Dimachkie; Laura Herbelin; Richard Barohn
Journal: Stat Med Date: 2015-01-07 Impact factor: 2.373

Review 3. Statistical considerations for the next generation of clinical trials.

Authors: Wenting Wu; Qian Shi; Daniel J Sargent
Journal: Semin Oncol Date: 2011-08 Impact factor: 4.929

Review 4. Drug development and clinical trials--the path to an approved cancer drug.

Authors: Eric H Rubin; D Gary Gilliland
Journal: Nat Rev Clin Oncol Date: 2012-02-28 Impact factor: 66.675

Review 5. Clinical cancer research: the past, present and the future.

Authors: Vincent T DeVita; Alexander M M Eggermont; Samuel Hellman; David J Kerr
Journal: Nat Rev Clin Oncol Date: 2014-09-23 Impact factor: 66.675

6. Clinical trial designs for testing biomarker-based personalized therapies.

Authors: Tze Leung Lai; Philip W Lavori; Mei-Chiung I Shih; Branimir I Sikic
Journal: Clin Trials Date: 2012-03-07 Impact factor: 2.486

7. Outcome--adaptive randomization: is it useful?

Authors: Edward L Korn; Boris Freidlin
Journal: J Clin Oncol Date: 2010-12-20 Impact factor: 44.544

8. Simulation study for evaluating the performance of response-adaptive randomization.

Authors: Yining Du; Xuan Wang; J Jack Lee
Journal: Contemp Clin Trials Date: 2014-11-11 Impact factor: 2.226

9. The BATTLE trial: personalizing therapy for lung cancer.

Authors: Edward S Kim; Roy S Herbst; Ignacio I Wistuba; J Jack Lee; George R Blumenschein; Anne Tsao; David J Stewart; Marshall E Hicks; Jeremy Erasmus; Sanjay Gupta; Christine M Alden; Suyu Liu; Ximing Tang; Fadlo R Khuri; Hai T Tran; Bruce E Johnson; John V Heymach; Li Mao; Frank Fossella; Merrill S Kies; Vassiliki Papadimitrakopoulou; Suzanne E Davis; Scott M Lippman; Waun K Hong
Journal: Cancer Discov Date: 2011-06-01 Impact factor: 39.397

Review 10. Predictive biomarkers: a paradigm shift towards personalized cancer medicine.

Authors: Nicholas B La Thangue; David J Kerr
Journal: Nat Rev Clin Oncol Date: 2011-08-23 Impact factor: 66.675

7 in total

1. A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.

Authors: Vinay K Puduvalli; Jing Wu; Ying Yuan; Terri S Armstrong; Elizabeth Vera; Jimin Wu; Jihong Xu; Pierre Giglio; Howard Colman; Tobias Walbert; Jeffrey Raizer; Morris D Groves; David Tran; Fabio Iwamoto; Nicholas Avgeropoulos; Nina Paleologos; Karen Fink; David Peereboom; Marc Chamberlain; Ryan Merrell; Marta Penas Prado; W K Alfred Yung; Mark R Gilbert
Journal: Neuro Oncol Date: 2020-10-14 Impact factor: 12.300

2. Adaptive Clinical Trials: Advantages and Disadvantages of Various Adaptive Design Elements.

Authors: Edward L Korn; Boris Freidlin
Journal: J Natl Cancer Inst Date: 2017-06-01 Impact factor: 13.506

3. A conceptual model for the development process of confirmatory adaptive clinical trials within an emergency research network.

Authors: Samkeliso C Mawocha; Michael D Fetters; Laurie J Legocki; Timothy C Guetterman; Shirley Frederiksen; William G Barsan; Roger J Lewis; Donald A Berry; William J Meurer
Journal: Clin Trials Date: 2017-01-31 Impact factor: 2.486